Characteristics | 1st stage (n = 28) | 2nd stage (n = 72) | ||
---|---|---|---|---|
n | % | n | % | |
Overall completion ratea | ||||
Fully completed | 10 | 36% | 52 | 72% |
Partially completed | 18 | 64% | 20 | 28% |
Response rate by affiliation | ||||
Governmental or other public institution | 14 | 50% | 33 | 46% |
Research institution | 12 | 43% | 26 | 36% |
International organization | 1 | 4%s | 0 | 0% |
Health care provider | 1 | 4% | 10 | 14% |
Non-profit organization | 0 | 0% | 3 | 4% |
Geographic distribution by regionb | ||||
West | 13 | 46% | 24 | 34% |
South | 7 | 25% | 27 | 36% |
North | 5 | 18% | 8 | 12% |
East | 2 | 7% | 11 | 15% |
Non-EU | 0 | 0% | 2 | 3% |
No response | 1 | 4% | 0 | 0% |
Level of HSPA expertise (1 = basic, 5 = expert) | ||||
1 (basic) | 1 | 4% | 0 | 0% |
2 | 5 | 18% | 9 | 13% |
3 | 3 | 11% | 26 | 36% |
4 | 7 | 25% | 21 | 29% |
5 (expert) | 12 | 43% | 14 | 19% |
No response | 0 | 0% | 2 | 3% |
Area of expertisec | ||||
Chronic Care | 7 | 25% | 9 | 13% |
Determinants Of Health | 12 | 43% | 32 | 43% |
Economics | 8 | 29% | 6 | 8% |
Elderly / Long-Term Care | 2 | 7% | 5 | 7% |
Environmental Health | 2 | 7% | 14 | 19% |
Epidemiology | 12 | 43% | 37 | 51% |
Ethical Issues | 0 | 0% | 6 | 8% |
Financing Health Care | 13 | 46% | 11 | 15% |
Health Economics | 19 | 68% | 19 | 26% |
Health Spending, Cost of Care | 14 | 50% | 9 | 13% |
Maternal And Child Health | 4 | 14% | 8 | 11% |
Organization and Delivery of Care | 9 | 32% | 15 | 21% |
Pharmaceuticals | 2 | 7% | 10 | 14% |
Quality of Care | 10 | 36% | 24 | 33% |
Workforce Issues | 5 | 18% | 4 | 6% |